JOINT Corp
JYNTNasdaq
$8.91
↓ -1.2%Jul 17 close · end-of-day
Price
1Y↓ -22.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$126.4M
Enterprise Value
$105.7M
P/E
38.7
P/S
2.2
P/B
8.2
EV/EBITDA
45.5
PEG
—
FCF Yield
2.1%
Dividend Yield
—
Revenue (TTM)
$56.6M
Net Income (TTM)
—
Free Cash Flow (TTM)
$2.7M
Gross Margin
—
Operating Margin
1.1%
Net Margin
—
ROE
—
ROIC
—
Debt / Equity
—
Net Cash
$20.7M
Return 1Y
-21.4%
Company profile
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. As of March 1, 2022, the company operated approximately 700 locations in the United States.
- CEO
- Peter D. Holt
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Trading
- Employees
- 320
- Headquarters
- Arizona
- Website
- thejoint.com
Management & directors
- Bowman Scott JustinChief Financial Officer
- Razdan Sanjiv KumarSee Remarks
Roles derived from SEC Form 4 filings.
Earnings
JYNT Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$14.8M↑ +13.3%
Diluted EPS$0.09↑ +50.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $58.7M | $80.0M | $101.3M | $117.7M | $52.2M | $54.9M |
| Gross profit | — | — | — | — | — | — |
| Operating income | $5.5M | $6.1M | -$1.9M | $318,299.00 | -$1.9M | -$913,376.00 |
| Net income | $13.2M | $7.6M | $626,705.00 | -$9.8M | -$5.8M | $2.9M |
| Diluted EPS | $0.90 | $0.51 | -$0.38 | -$0.65 | -$0.38 | $0.19 |
| Operating cash flow | $11.2M | $13.8M | $8.2M | $14.7M | $9.4M | $1.8M |
| Free cash flow | $8.0M | $6.9M | $2.3M | $9.7M | $8.2M | $334,724.00 |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 9.4% | 7.7% | -1.9% | 0.3% | -3.6% | -1.7% |
| Net margin | 22.4% | 9.5% | 0.6% | -8.3% | -11.1% | 5.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $30.3M | $30.2M | $14.7M | $13.1M | $13.3M | $13.4M | $15.2M | $14.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$1.8M | -$492,820.00 | $809,716.00 | -$678,534.00 | -$1.1M | $160,915.00 | $742,410.00 | $873,668.00 |
| Net income | -$3.6M | -$3.2M | $17,665.00 | — | — | — | — | — |
| Diluted EPS | -$0.24 | -$0.21 | $0.00 | $0.06 | $0.01 | $0.06 | $0.07 | $0.09 |
| Operating cash flow | -$973,456.00 | $3.4M | $4.1M | -$3.7M | $868,649.00 | $1.8M | $2.9M | -$1.5M |
| Free cash flow | -$1.2M | $3.2M | $3.8M | -$4.0M | $363,609.00 | $1.5M | $2.5M | -$1.7M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -5.9% | -1.6% | 5.5% | -5.2% | -8.6% | 1.2% | 4.9% | 5.9% |
| Net margin | -11.9% | -10.5% | 0.1% | — | — | — | — | — |
Company news
May 8, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-10 | Bowman Scott Justin· Chief Financial Officer | Tax withholding | 1,392 | $8.43 | $11,734.56 | filing |
| 2026-05-20 | Pant Milind | Award | 5,714 | $0.00 | $0.00 | filing |
| 2026-05-20 | Karrmann Sandra R | Award | 5,714 | $0.00 | $0.00 | filing |
| 2026-05-20 | Grandpre Christopher M | Award | 5,714 | $0.00 | $0.00 | filing |
| 2026-05-20 | DaVella Ronald V | Award | 5,714 | $0.00 | $0.00 | filing |
| 2026-05-20 | Rubel Matthew E | Award | 5,714 | $0.00 | $0.00 | filing |
| 2026-05-13 | JOBSON CHARLES E | Buy | 20,375 | $8.57 | $174,613.75 | filing |
| 2026-05-12 | JOBSON CHARLES E | Buy | 127,676 | $8.57 | $1.1M | filing |
| 2026-04-21 | JOBSON CHARLES E | Buy | 509 | $8.58 | $4,367.22 | filing |
| 2026-03-09 | Bowman Scott Justin· Chief Financial Officer | Award | 28,301 | $0.00 | $0.00 | filing |
| 2026-03-09 | Razdan Sanjiv Kumar· See Remarks | Award | 73,484 | $0.00 | $0.00 | filing |
| 2026-02-12 | JOBSON CHARLES E | Buy | 15,397 | $8.50 | $130,874.50 | filing |
| 2026-02-11 | JOBSON CHARLES E | Buy | 448 | $8.70 | $3,897.60 | filing |
| 2026-01-26 | JOBSON CHARLES E | Buy | 725 | $10.00 | $7,250.00 | filing |
| 2026-01-23 | JOBSON CHARLES E | Buy | 16,753 | $10.00 | $167,530.00 | filing |
| 2026-01-02 | JOBSON CHARLES E | Buy | 1,393 | $8.70 | $12,119.10 | filing |
| 2025-12-31 | JOBSON CHARLES E | Buy | 11 | $8.70 | $95.70 | filing |
| 2025-12-05 | JOBSON CHARLES E | Buy | 10,000 | $8.41 | $84,100.00 | filing |
| 2025-12-01 | JOBSON CHARLES E | Buy | 13,000 | $8.41 | $109,330.00 | filing |
| 2025-11-25 | JOBSON CHARLES E | Buy | 2,081 | $8.43 | $17,542.83 | filing |
| 2025-11-24 | JOBSON CHARLES E | Buy | 4,680 | $8.36 | $39,124.80 | filing |
| 2025-11-21 | JOBSON CHARLES E | Buy | 10,000 | $8.50 | $85,000.00 | filing |
| 2025-08-20 | Grandpre Christopher M | Buy | 10,000 | $10.41 | $104,082.00 | filing |
| 2025-08-18 | Grandpre Christopher M | Buy | 10,000 | $10.70 | $106,978.00 | filing |
| 2025-08-15 | Grandpre Christopher M | Buy | 14,388 | $10.88 | $156,531.37 | filing |
Latest 25 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.